IDO1 and neoplasm: The complex interactions within the TME, including the presence of immune cells such as tumor-infiltrating lymphocytes (TILs) and the expression of immune checkpoint molecules like PD-1, LAG-3, and IDO, play crucial roles in determining the response to immunotherapy (11, 13).